Search Results - "Lockhart, Staci M."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Dolutegravir, a Second-Generation Integrase Inhibitor for the Treatment of HIV-1 Infection by Rathbun, R. Chris, Lockhart, Staci M., Miller, Misty M., Liedtke, Michelle D.

    Published in Annals of Pharmacotherapy (01-03-2014)
    “…Objective: To review the pharmacology, safety, and efficacy of dolutegravir, an integrase strand-transfer inhibitor (INSTI), and to discuss its role in the…”
    Get full text
    Book Review Journal Article
  2. 2

    The role of dolutegravir in the management of HIV infections by Miller, Misty, Liedtke, Michelle D., Rathbun, R. Chris, Lockhart, Staci M.

    Published in Infection and drug resistance (01-02-2015)
    “…Dolutegravir is the most recent integrase strand transfer inhibitor approved for HIV-1 infection in both treatment-naïve and experienced patients. As a…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The role of dolutegravir in the management of HIV infection by Miller, Misty M, Liedtke, Michelle D, Lockhart, Staci M, Rathbun, R Chris

    Published in Infection and drug resistance (01-01-2015)
    “…Dolutegravir is the most recent integrase strand transfer inhibitor approved for HIV-1 infection in both treatment-naïve and experienced patients. As a…”
    Get full text
    Journal Article
  6. 6

    Incidence of Transmitted Antiretroviral Drug Resistance in Treatment-Naive HIV-1-Infected Persons in a Large South Central United States Clinic by Kleyn, Thomas J., Liedtke, Michelle D., Harrison, Donald L., Lockhart, Staci M., Salvaggio, Michelle R., Ripley, Toni L., Rathbun, R. Chris

    Published in The Annals of pharmacotherapy (01-04-2014)
    “…Background: Transmitted drug resistance (TDR) can limit effective treatment options to antiretroviral-naive HIV-infected persons and increase the risk of…”
    Get full text
    Journal Article
  7. 7

    Long-term efficacy and safety of raltegravir in the management of HIV infection by Liedtke, Michelle D, Tomlin, C Ryan, Lockhart, Staci M, Miller, Misty M, Rathbun, R Chris

    Published in Infection and drug resistance (01-01-2014)
    “…Raltegravir is an integrase strand-transfer inhibitor approved for the treatment of HIV infection. It was the first medication in a novel class of…”
    Get full text
    Journal Article
  8. 8

    Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: A prospective, randomized, controlled pilot study by Chris Rathbun, R., Farmer, Kevin C., Stephens, Johnny R., Lockhart, Staci M.

    Published in Clinical therapeutics (01-02-2005)
    “…The aim of this randomized, controlledpilot study was to examine the impact of a pharmacistoperated adherence clinic on adherence to highly active…”
    Get full text
    Journal Article
  9. 9

    Validity of a Stage of Change Instrument in Assessing Medication Adherence in Indigent Patients with HIV Infection by Rathbun, R Chris, Farmer, Kevin C, Lockhart, Staci M, Stephens, Johnny R

    Published in The Annals of pharmacotherapy (01-02-2007)
    “…Background: Adherence to antiretroviral therapy (ART) is vital to achieve durable suppression of viral replication. Effective mechanisms to predict adherence…”
    Get full text
    Journal Article
  10. 10

    Anticonvulsant and Antiretroviral Interactions by Liedtke, Michelle D, Lockhart, Staci M, Rathbun, R Chris

    Published in The Annals of pharmacotherapy (01-03-2004)
    “…OBJECTIVE To evaluate the clinical significance of interactions between anticonvulsant and antiretroviral agents and provide recommendations regarding their…”
    Get full text
    Journal Article
  11. 11

    Cutaneous reactions with tenofovir disoproxil fumarate : a report of nine cases by LOCKHART, Staci M, RATHBUN, R. Chris, STEPHENS, Johnny R, BAKER, Damon L, DREVETS, Douglas A, GREENFIELD, Ronald A, SALVAGGIO, Michelle R, VINCENT, Simi

    Published in AIDS (London) (19-06-2007)
    “…Adverse drug reactions causing the early discontinuation of therapy are common in patients with HIV infection. Hypersensitivity consisting mainly of a…”
    Get full text
    Journal Article
  12. 12

    Congestive Heart Failure Exacerbation Secondary to Itraconazole Therapy by Liedtke, Michelle D, Vandaveer, Julie K, Greenfield, Ronald A, Lockhart, Staci M

    “…Itraconazole is a commonly prescribed antifungal agent that has been associated with the occurrence of congestive heart failure (CHF) symptoms. There is…”
    Get full text
    Journal Article
  13. 13

    Successful 4-Drug Treatment for Refractory Giardia lamblia by Ramsey, Nathan C, Liedtke, Michelle D, Greenfield, Ronald A, Lockhart, Staci M

    “…Refractory Giardia lamblia is uncommon and often occurs in the presence of comorbidities or immunosuppression. Combination therapy is warranted in such cases,…”
    Get full text
    Journal Article
  14. 14

    Evaluating the impact of a pre-rotation workshop on student preparation for clinical advanced pharmacy practice experiences by Medina, Melissa S., Stark, Jennifer E., Vesta, Kimi S., Lockhart, Staci M.

    “…ABSTRACT* Objectives: This pilot study was designed to evaluate the impact of a pre-rotation workshop (PRW) on pharmacy students clinical skills and…”
    Get full text
    Journal Article
  15. 15

    Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir by Rathbun, Chris R, Liedtke, Michelle D, Blevins, Steve M, Harrison, Donald, Lockhart, Staci M, Salvaggio, Michelle, Acosta, Edward P

    Published in HIV clinical trials (01-09-2009)
    “…Concurrent atazanavir (ATV) and lopinavir/ritonavir (LPV/r) may be useful for patients with extensive antiretroviral resistance; however, limited information…”
    Get more information
    Journal Article
  16. 16

    Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza by Lockhart, Staci M, Salvaggio, Michelle R, Bronze, Michael S, Greenfield, Ronald A

    “…The incidences of viral infectious diseases are increasing at an alarming rate in the US and worldwide. Antiviral therapy is challenging because viruses…”
    Get more information
    Magazine Article
  17. 17

    Part XV. Antiretroviral therapy for human immunodeficiency virus infection by Stephens, Johnny R, Rathbun, R Chris, Lockhart, Staci M, Bronze, Michael S, Greenfield, Ronald A

    “…Twenty six years have passed since the first cases of the acquired immune deficiency syndrome (AIDS) were recognized in the U.S. Since that time, over 25…”
    Get more information
    Magazine Article
  18. 18